🔥 CYBER MONDAY SALE ENDS TONIGHT: Save 30% or more on all Examine products
Save now
»
| Effect | Decrease |
| Trial Design | Cohort |
| Trial Length | 6+ Months |
| Number of Subjects | 22 |
| Sex | Both Genders |
| Age Range | 30-44 |
| Body Types | Overweight |
Supplementation of alpha-tocopherol (300mg) daily for one year in persons with NAFLD after a six month introductory period (lifestyle and diet modification) noted that the addition of vitamin E was able to reduce circulating ALT in persons with NAFLD but not steatohepatitis although fibrotic, inflammation, and steatitis scores of those with steatohepatitis were improved with vitamin E; both groups experienced a reduction in circulating TGF-b.
